Original Article
Boonthida Joyjumroon, Sunee Bovonsunthonchai, Nuttapol Aoonkaew, Atthapol Raksthaput, Vorapun Senanarong
Alzheimer’s disease, the leading type of
dementia globally, is marked by gradual memory
loss and deterioration in various cognitive functions,
including gait, especially dual-task gait.1
At present,
pharmacological therapies are the most common
treatments for Alzheimer’s disease, especially
acetylcholinesterase inhibitors (AchEI), which
reduce the degradation of acetylcholine, an essential
neurotransmitter associated with memory functions.
However...
เมษายน - มิถุนายน 2569